Objective. To create a pediatric rheumatology Top 5 list as part of the American Board of Internal Medicine Foundation's Choosing Wisely campaign.Methods. Delphi surveys of a core group of representative pediatric rheumatology providers from across North America generated candidate Top 5 items. Items with high content agreement and perceived to be of prevalent use and of high impact were included in a survey of all American College of Rheumatology (ACR) members who identified themselves as providing care to pediatric patients. Items with the highest ratings were subjected to literature review and further evaluation. Results. A total of 121 candidate items were proposed in the initial Delphi survey and were reduced to 28 items in subsequent surveys. These 28 items were sent to 1,198 rheumatology providers who care for pediatric patients, and 397 (33%) responded. Based upon survey data and literature review, the Top 5 items were identified. These items focused on testing for antinuclear antibodies, autoantibody panels, Lyme disease, methotrexate toxicity monitoring, and use of routine radiographs. Conclusion. The ACR pediatric rheumatology Top 5 is one of the first pediatric subspecialty-specific Choosing Wisely Top 5 lists and provides an opportunity for patients and providers to discuss appropriate use of health care in pediatric rheumatology. whose routine use, based upon available evidence, may add to the cost of care without improving quality of care. As the US struggles to reduce health care costs without jeopardizing quality of care, physician involvement is needed to develop strategies to reduce health care spending (1). In 2011, the ABIM Foundation launched the Choosing Wisely campaign, encouraging medical societies to identify sources of unnecessary spending. Partnering societies were charged with developing a Top 5 list of tests, treatments, or services commonly used by that specialty that have high aggregate costs and are unnecessary or potentially harmful. Recommendations were based on clinical guidelines and available evidence (2). The Top 5 lists are intended to be widely disseminated to physicians and patients, prompting discussions about the utility and optimal use of these tests and interventions (3). The Top 5 list aims to raise awareness of potentially wasteful interventions but not replace clinical judgment or individualized care, and each item includes information about when the test or procedure may be appropriate.
The American College ofTo date, 51 medical societies have participated in the Choosing Wisely campaign (3), and in March 2013, the ACR published a Top 5 list (4). Given the unique needs of the pediatric rheumatology population, the ACR supported the parallel development of this ACR pediatric rheumatology Top 5 list. This list is the product of a multistep process that included survey and consensus techniques and extensive literature reviews, ensuring that the final items reflect expert opinion and best available evidence.
MATERIALS AND METHODSThe ACR Special Committee on Pediatric...